Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 1142  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission

Year : 2013  |  Volume : 5  |  Issue : 1  |  Page : 61-65

A validated RP-HPLC method for simultaneous determination of propranolol and valsartan in bulk drug and gel formulation

1 Department of Pharmaceutics, Faculty of Pharmacy, Hamdard University, New Delhi, India
2 Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

Correspondence Address:
Mohammed Aqil
Department of Pharmaceutics, Faculty of Pharmacy, Hamdard University, New Delhi
Login to access the Email id

Source of Support: All India Council for Technical Education (AICTE), New Delhi, (Grant # 8023/BOR/RPS.157/2006.07), Conflict of Interest: None

DOI: 10.4103/0975-7406.106573

Rights and Permissions

Objective: A simple, precise, and stability indicating high performance liquid chromatography (HPLC) method was developed and validated for the simultaneous determination of propranolol hydrochloride and valsartan in pharmaceutical dosage form. Materials and Methods: The method involves the use of easily available inexpensive laboratory reagents. The separation was achieved on Hypersil ODS C-18 column (250*4.6 mm, i.d., 5 μm particle size) with isocratic flow with UV detector. The mobile phase at a flow rate of 1.0 mL/min consisted of acetonitrile, methanol, and 0.01 M disodium hydrogen phosphate (pH 3.5) in the ratio of 50:35:15 v/v. Results: A linear response was observed over the concentration range 5-50 μg/mL of propranolol and the concentration range 4-32 μg/mL of valsartan. Limit of detection and limit of quantitation for propranolol were 0.27 μg/mL and 0.85 μg/mL, and for valsartan were 0.45 μg/mL and 1.39 μg/mL, respectively. The method was successfully validated in accordance to ICH guidelines acceptance criteria for linearity, accuracy, precision, specificity, robustness. Conclusion: The analysis concluded that the method was selective for simultaneous estimation of propranolol and valsartan can be potentially used for the estimation of these drugs in combined dosage form.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded229    
    Comments [Add]    
    Cited by others 6    

Recommend this journal